Pressure BioSciences (PBIO)
(Delayed Data from OTC)
$0.03 USD
-0.01 (-26.32%)
Updated Sep 20, 2024 12:48 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Pressure BioSciences Inc. [PBIO]
Reports for Purchase
Showing records 61 - 80 ( 80 total )
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
ValuEngine Detailed Valuation Report for PBIO
Provider: VALUENGINE, INC
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
We are maintaining our Neutral rating due to heightened concerns about the company?s ability to raise sufficient capital.
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
We are reiterating our investment rating of Speculative Buy
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Reiterating our investment rating of Speculative Buy and maintaining a 12-month price target of $2.30 per share.
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
We are reiterating our investment rating of Speculative Buy
Provider: Taglich Brothers, Inc.
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
We are reiterating our investment rating of Speculative Buy
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Pressure BioSciences Inc.
Industry: Medical - Instruments
We are reiterating our investment rating of Speculative Buy but have lowered our 12-month price target to $2.30 per share
Provider: Taglich Brothers, Inc.
Analyst: NOBLE J